Company / Operating Income
enGene Holdings Inc. Operating Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$123.2M
FY2025
5-year range
-$123.2M / -$19.4M
FY2022-FY2025
Trend
-97.7%
vs FY2024
Sector context
#106 of 202
Health Care
What the data says
At -$123M, enGene Holdings Inc.'s operating income ranks #106 of 202 in the Health Care sector. Operating Income has declined for 3 consecutive years, from -$19M in FY2022 to -$123M in FY2025.
Based on SEC 10-K filings.
-$123M in FY2025.
Declined from -$26M to -$123M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 202 in Health CareTop 52% of 202This company -$123.2M Sector average $70.7M
▼
-274.2% below sector average
Key checks
Key Insights
- enGene Holdings Inc.'s operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 97.7% year-over-year.
- Ranks #106 out of 202 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$123.2M | -97.7% |
| FY2024 | -$62.3M | -139.1% |
| FY2023 | -$26.1M | -34.1% |
| FY2022 | -$19.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026